Concern J&J may give Indian hip patients worse deal than US patients

Johnson & Johnson has said it will cover the costs of testing and treating patients in India who had been implanted with the company’s faulty ASR hip devices. However, some experts believe that Indian patients may be getting a raw deal compared with US patients because they are less organized and because most are unaware of the complications the device could have posed. Many may also be unaware of the company's efforts to reach out to them, the experts emphasize.